ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
3
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,412
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
Author(s):
U Matulonis
,
GM Wulf
,
MJ Birrer
Publication date:
2014
Journal:
J. Clin. Oncol.
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Immunotherapy
Data availability:
ScienceOpen disciplines:
Molecular medicine
,
Life sciences
Comments
Comment on this article
Sign in to comment
Similar content
3,412
SUN-004 Unique Cell Fates and Metastatic Phenotypes Are Activated by Progesterone Receptor (PR) Isoform-specific Gene Expression in Fallopian Tube Models of HGSC
Authors:
Megan Seibel
,
Angela Spartz
,
Ronny Drapkin
…
Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report
Authors:
Kazuaki Suda
,
Hirofumi Nakaoka
,
Chihiro Hata
…
VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
Authors:
R.L. Coleman
,
G.F. Fleming
,
M.F. Brady
…
See all similar
Cited by
3
Targeting PI3K/Akt signal transduction for cancer therapy
Authors:
Yan He
,
Miao Sun
,
Guo Zhang
…
Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives
Authors:
Giovanni Di Lorenzo
,
Giuseppe Ricci
,
Giovanni Maria Severini
…
Role of Biomarkers in the Development of PARP Inhibitors
Authors:
Bratati Ganguly
,
Sonia Dolfi
,
Lorna Rodriguez-Rodriguez
…
See all cited by